T2 BIOSYSTMS INC

NASDAQ: TTOO (T2 Biosystems, Inc.)

Last update: 6 hours ago

0.002

0.00 (450.00%)

Previous Close 0.000
Open 0.012
Volume 35
Avg. Volume (3M) 50,088
Market Cap 61,699
52 Weeks Range
0.000 (-95%) — 0.180 (8081%)
Earnings Date 28 Jul 2025 - 1 Aug 2025
Operating Margin (TTM) -511.89%
Diluted EPS (TTM) -0.030
Quarterly Revenue Growth (YOY) 34.90%
Current Ratio (MRQ) 0.400
Operating Cash Flow (TTM) -36.59 M
Levered Free Cash Flow (TTM) -26.37 M
Return on Assets (TTM) -84.85%

Market Trend

Short Term Medium Term
Industry Diagnostics & Research (US) Mixed Bullish
Diagnostics & Research (Global) Mixed Bullish
Stock T2 Biosystems, Inc. Mixed Mixed

AIStockmoo Score

0.2
Analyst Consensus NA
Insider Activity NA
Price Volatility -2.0
Technical Moving Averages 2.5
Technical Oscillators 0.0
Average 0.17

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
TTOO 62 K - - -
OPK 949 M - - 0.710
PSNL 703 M - - 2.91
MYGN 480 M - - 1.18
FLGT 436 M - - 0.440
PRE 363 M - - 2.01

T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company’s products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.

Sector Healthcare
Industry Diagnostics & Research
Investment Style Small Value
% Held by Insiders 8.07%
% Held by Institutions 38.15%

Ownership

Name Date Shares Held
Horizon Financial Services, Llc 31 Dec 2025 9
Union Bancaire Privee, Ubp Sa 31 Dec 2025 1

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria